---

$10.24

+0.0350 ( +0.34% ) 3.3M

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. Novavax works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The Company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from Europe.

Type: All Buy Sale Start date: End date: Filter Reset

Date	Type	Amount Purchased	Purchaser
2024-06-25	Sale	-7500.00	YOUNG JAMES F
2024-06-21	Sale	-6393.00	YOUNG JAMES F
2024-03-12	Sale	-5376.00	Dubovsky Filip
2024-03-12	Sale	-4608.00	Trizzino John
2024-03-11	Sale	-12224.00	Kelly James Patrick
2024-03-11	Sale	-28890.00	Trizzino John
2024-03-11	Sale	-19444.00	Dubovsky Filip
2024-03-05	Sale	-19600.00	O'Hara Elaine
2024-01-25	Sale	-83197.00	Jacobs John C
2023-12-18	Sale	-2100.00	Herrmann John A III